ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
147K |
14 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
818
|
147K
|
14
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Notification of Expiry of Listed Options
|
|
64palms
|
6 |
1.1K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
6
|
1.1K
|
1
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
252
|
68K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
124 |
25K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
124
|
25K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
252
|
68K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
252
|
68K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
252
|
68K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
252
|
68K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
252
|
68K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
124 |
25K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
124
|
25K
|
3
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
147K |
5 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
818
|
147K
|
5
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
147K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
818
|
147K
|
2
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
147K |
20 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
818
|
147K
|
20
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
252
|
68K
|
0
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
124 |
25K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
124
|
25K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
124 |
25K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
124
|
25K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
124 |
25K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
124
|
25K
|
0
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
124 |
25K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
124
|
25K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
252
|
68K
|
0
|
|
ASX - By Stock
|
PLL |
Re:
Ann: Carolina Lithium State Mining Permit
|
|
64palms
|
151 |
52K |
5 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
151
|
52K
|
5
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
147K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
818
|
147K
|
0
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
147K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
818
|
147K
|
2
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
147K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
818
|
147K
|
4
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
124 |
25K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
124
|
25K
|
5
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
124 |
25K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
124
|
25K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: 3Q FY24 results update
|
|
64palms
|
460 |
81K |
11 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
460
|
81K
|
11
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
147K |
11 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
818
|
147K
|
11
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
252
|
68K
|
1
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
252
|
68K
|
3
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
6 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
252
|
68K
|
6
|
|
ASX - By Stock
|
MNB |
Re:
Ann: Minbos Investor Presentation - Angola Rising
|
|
64palms
|
605 |
130K |
8 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
605
|
130K
|
8
|
|
ASX - By Stock
|
MNB |
Re:
Ann: Minbos Investor Presentation - Angola Rising
|
|
64palms
|
605 |
130K |
12 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
605
|
130K
|
12
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNBV MoU Webinar presentation
|
|
64palms
|
88 |
16K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
88
|
16K
|
3
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNBV MoU Webinar presentation
|
|
64palms
|
88 |
16K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
88
|
16K
|
4
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
124 |
25K |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
124
|
25K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
124 |
25K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
124
|
25K
|
4
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
2 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
252
|
68K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
252
|
68K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
252
|
68K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
4
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
5
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
6 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
6
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
9 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
9
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
5
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
1
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
3
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
252 |
68K |
6 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
252
|
68K
|
6
|
|